CMA1 and COVID-19: Our studies show the simultaneous increase in CMA1, CPA3, and TPSB2 in COVID-19 patients, which are indicative of the MCTC subset of MCs (the most common subset in human airways) in the lungs of patients with COVID-19 (35).